- Unimicron’s first quarter net income surpassed the estimates at NT$2.43 billion, as opposed to the predicted NT$1.75 billion.
- The operating profit, however, fell short of the estimated NT$1.7 billion, coming in at NT$1.58 billion.
- Earnings per share (EPS) increased to NT$1.60, beating the estimate of NT$1.20.
- This quarter’s revenue outperformed projections, with Unimicron gathering NT$26.40 billion instead of the estimated NT$25.85 billion.
- The company currently holds a positive outlook from the majority of analysts, with 15 buying recommandations, 5 holds, and just 1 sell.
A look at Unimicron Technology Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Unimicron Technology Corp. exhibits a promising long-term outlook based on the Smartkarma Smart Scores assessment. With a solid score of 5 in Growth, the company is poised for significant expansion and development in the coming years. Complementing this, Unimicron also boasts high scores in Dividend and Resilience, with ratings of 4, indicating a stable and rewarding investment opportunity for shareholders looking for consistent returns.
Furthermore, Unimicron Technology‘s overall outlook is underpinned by its proficient performance in the areas of Value and Momentum, scoring 3 in both categories. This suggests a balanced approach towards value creation and sustainable growth potential. With its core business focusing on the manufacturing and marketing of printed circuit boards and integrated circuit services, Unimicron Technology Corp. demonstrates a resilient and growth-oriented business model, positioning itself as a viable investment option in the tech sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
